A Chester County biopharmaceutical company working on treatments for a variety of fibrotic and inflammatory diseases has a new chief executive officer.
Lindy Biosciences, a biotech company developing innovative drug formulation technology, announced today it has completed a $1.6M Series A round. The financing was led by Alumshares and BlueTree Allied Angels with participation by IAG Capital Partners, the Charleston Angel Conference, and Next Act Fund.
ESPN’s Monday Night Football heads into the 2019 NFL season with a new graphics look, a new director, and some new sideline-camera technology that promises to bring viewers a little closer to the action, courtesy of being located in the first-down marker as well as line-to-gain pylons.
Silicon Valley-based early-stage investor Plug and Play Tech Center chose Pittsburgh-based BlastPoint Inc. as part of its fifth Energy and Sustainability Group, according to a news release.
PITTSBURGH, PA September 3- ANSYS (NASDAQ: ANSS) is collaborating with Edge Case Research to engineer the next generation of autonomous vehicles (AV) with unmatched state-of-the-art hazard detection capabilities.
Companies looking to bring to market the next great solution to a thorny problem in medical care for children and adolescents are forming across the nation. The market is ripe for disruptive ideas, but to succeed, entrepreneurs have to show investors and clinicians that what they’re selling can truly make a difference.
BERWYN, PA, August 19, 2019 – Complexa Inc. today announced the appointment of Theodore (Theo) Danoff, MD, PhD, as Chief Medical Officer. Dr. Danoff formerly served as Chief Medical Officer and Senior Vice President, Clinical and Medical Affairs for Clarus Therapeutics where he led strategy and oversight for all aspects of clinical development and medical affairs as well as regulatory affairs.
The medical device industry is facing a generational change in the regulation and validation of its products. Today, more than ever, physicians, patients, and payers are demanding solid evidence that the devices they prescribe, use, and pay for performs to the highest standards and is backed by significant clinical data. In many cases, these standards are being driven by hospital value analysis committees, who increasingly act as gatekeepers for their institutions.
Local Pittsburgh program “Our Regions Business” features ALung.
Christiana Care Health System is participating in national research that may provide a non-invasive alternative to a ventilator for patients with severe chronic obstructive pulmonary disease (COPD).